MOSCOW, January 22 (Sputnik) — Russian HIV vaccine has passed the second phase of clinical trial, Oleg Salagai, spokesperson for the Russian Health Ministry told journalists Thursday.
In May 2014, during the Fourth Conference on HIV/AIDS in Eastern Europe and Central Asia, three prototypes of the candidate HIV vaccines were developed, according to the spokesperson.
Currently, analysis of the clinical trial results is being carried out, the Ministry representative noted. After the analysis is completed, the development projects on HIV effective vaccines will continue.
HIV, human immunodeficiency virus, causes AIDS, the acquired immunodeficiency syndrome. HIV infection is transferred with blood and other bodily fluids.
According to the World Health Organization, 35 million of people were living with HIV and 1.5 million people died of HIV-related illnesses, as of December 2013. There is no effective HIV vaccine yet.
